Does BREXUCABTAGENE AUTOLEUCEL Cause Diffuse large b-cell lymphoma recurrent? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 0.3% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
5
Reports of Diffuse large b-cell lymphoma recurrent with BREXUCABTAGENE AUTOLEUCEL
0.3%
of all BREXUCABTAGENE AUTOLEUCEL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From BREXUCABTAGENE AUTOLEUCEL?
Of the 5 reports.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (827)
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Disease progression (93)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE